4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000950170-25-023166
Chief Legal Officer sold 10,000 shares at $34.00 ($340,000)
- Chief Legal Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bellon Christine Chief Legal Officer | 2025-02-14 | Option exercise 10b5-1 | +9,492 | $7.22 | $68,532 | 112,460 | D |
| Bellon Christine Chief Legal Officer | 2025-02-14 | Option exercise 10b5-1 | +508 | $7.22 | $3,668 | 112,968 | D |
| Bellon Christine Chief Legal Officer | 2025-02-14 | Sale 10b5-1 | −10,000 | $34.00 | $340,000 | 102,968 | D |
| Derivatives | |||||||
| Bellon Christine Chief Legal Officer | 2025-02-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,492 | 0 | D | ||
| Bellon Christine Chief Legal Officer | 2025-02-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −508 | 10,410 | D | ||
| Open-market sales · 10,000 sh · avg $34.00 · $340,000 | |||||||
Loading xslF345X05/ownership.xml…